# A Study to Describe the Effectiveness of Arrhythmia Analysis Software for Screening of Sinus Rhythm, Atrial Fibrillation and Premature Beats in light-and Dark Skin Tone Patients

> **NCT05437926** · — · UNKNOWN · sponsor: **Huawei Device Co., Ltd** · enrollment: 102 (estimated)

## Conditions studied

- Arrhythmia, Cardiac

## Interventions

- **DEVICE:** Arrhythmia Analysis Software (software) which runs on a mobile application (Huawei Phone) and uses input from a wearable device (smart watch or smart band).

## Key facts

- **NCT ID:** NCT05437926
- **Lead sponsor:** Huawei Device Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-21
- **Primary completion:** 2023-07-21
- **Final completion:** 2023-09-21
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2023-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05437926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05437926, "A Study to Describe the Effectiveness of Arrhythmia Analysis Software for Screening of Sinus Rhythm, Atrial Fibrillation and Premature Beats in light-and Dark Skin Tone Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05437926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*